home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Anadolu Medical Center

SHARESHARESHARE
Anadolu Medical Center is sheltered by the Anadolu Foundation and it is characterized by two major aspects : its non-profit status and its unique affiliation with the world praised Johns Hopkins Medicine. Dedication to health and wellness has been a top priority since the begining, when the two prominent families, Yazıcı and Özilhan established the Anadolu Foundation in 1979. Anadolu is the center of excellence in advanced technology in oncology treatment ( PET-CT, CyberKnife, TrueBeam, Bone Marrow Transplantation). These leading programs conducted by a team of internationally experienced doctors are recognized in Turkey and beyond.
SHARESHARESHARE

RELATED NEWS


NeuroSigma’s Monarch eTNS might be the first device to treat ADHD, but it is one of a growing number of technologies that occupy the burgeoning bioelectronic medicine space. The Monarch external Trigeminal Nerve Stimulation (eTNS) System made history last week after it became the first device to win a nod from FDA to treat attention deficit hyperactivity disorder (ADHD). It should be noted the technology has had CE mark since 2015. Monarch was developed by NeuroSigma and is indicated to he...

READ MORE

Jagdish Singh, chair and professor of pharmaceutical sciences in the College of Health Professions at North Dakota State University, Fargo, is receiving a $1.89 million grant award for an Alzheimer’s disease study. The goal of the research is to develop a new delivery system that uses neurotrophic growth factor to treat and prevent Alzheimer’s disease. The grant from the National Institute on Aging of the National Institutes of Health spans five years....
NEWSWISE
READ MORE

GenScript USA Inc., the world's leading research reagent provider, announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. This is the first commercially available test to specifically detect neutralizing antibodies without the use of live virus. Neutralizing antibodies, a subset of antibodies that are specifically able to block the ability of the virus to enter a cel...
PRNEWSWIRE
READ MORE

A court has backed NHS England in a case where US pharma giant AbbVie had alleged that its procurement process for hepatitis C drugs was unfair. NHS England aims to eliminate hepatitis C by 2025 using the ‘largest ever’ drug procurement process, inviting pharma companies to take part in the initiative worth almost a billion pounds over five years. But AbbVie had claimed the NHS breached its duty to treat all bidders fairly and started court proceedings last year. NHS England said the...

READ MORE

Amgen and UCB have suffered a setback to their osteoporosis drug, romosozumab, after first phase 3 trial results revealed a heart safety signal. Evenity, as it will be branded if approved, is under review with the FDA, which had been due to make a decision on the drug in July....

READ MORE

GlaxoSmithKlines been dreading generic Advair for years, but thanks to its newer respiratory meds and the fast-launching Shingrix vaccine, the companys top line is so far managing to hold its own. Mylan launched Wixela Inhub, the first true Advair copycat, in February, and sales of the GSK behemoth plummeted a whopping 61% in the U.S. in the second quarter, to merely £105 million ($131 million). And the new generic put pricing pressure on all similar products, dealing a blow to the rest of...

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...